Synonyms: CK-274 | CK-3773274 | CK3773274
Compound class:
Synthetic organic
Comment: Aficamten (CK-3773274) is an orally administered cardiac myosin inhibitor that was developed by Cytokinetics as a potential treatment for hypertrophic cardiomyopathies [1-3,6]. It was designed to reduce the hypercontractility of cardiac sarcomeres that is thought to drive hypertrophy and fibrosis in heart muscle, by binding directly to a distinct and selective allosteric binding site on cardiac myosin.
|
|
Bioactivity Comments |
CK-274 inhibits myosin ATPase activity (in bovine cardiac myofibrils) with IC50 1.4 μM [3]. |